Key facts
- Notable investors include Miracleplus, Zhengxuan Investment, Mornway Capital, Next Capital (China), iFlytek Startups.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for BrainClos
- ·The full record, as it builds
Funding rounds
No funding rounds for BrainClos are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BrainClos
Manufacturer of non invasive neuromodulation therapy devices intended for the neurological diagnostics industry. The company's offerings include closed loop neuromodulation systems, non invasive brain function imaging tools and therapeutic devices targeting stroke, depression, ADHD, autism, and Alzheimer's disease, thereby enhancing therapeutic precision by providing safer, more accessible options for patients requiring neurological care.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2020
- Website
- mybrainclos.com/
- Ownership
- Privately Held (backing)
BrainClos doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrainClos shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrainClos in its N-PORT filings yet. We sweep new filings monthly.